Clinical Trial Update: Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating CSL112 in subjects with acute coronary syndrome has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CSL112

Snippet

Sponsor: CSL Behring | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2025-01-14